Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

Market Cap	2.66B
Revenue (ttm)	260.36M
Net Income (ttm)	52.10M
Shares Out	160.00M
EPS (ttm)	0.32
PE Ratio	51.83
Forward PE	n/a
Dividend	0.30 (1.81%)
Ex-Dividend Date	May 28, 2025

Volume	8,612,196
Average Volume	4,293,118
Open	16.08
Previous Close	16.54
Day's Range	16.08 - 16.97
52-Week Range	10.35 - 17.06
Beta	0.22
RSI	70.50
Earnings Date	Aug 26, 2025

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 316
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300519

Financial Performance

In 2024, SHE:300519's revenue was 267.66 million, a decrease of -1.01% compared to the previous year's 270.40 million. Earnings were 50.39 million, a decrease of -21.70%.